Episode #44
Underfunded Areas of Women's Health - Part 1
Women's health has historically been overlooked in research and investment, but that landscape is beginning to change. In this episode of The Positive Pause ®, host Claire Gill talks with Sabrina Martucci Johnson, President & CEO of Daré Bioscience, about what it really takes to develop safe, effective therapies for women and why informed patients play such an important role in advancing better healthcare. Their discussion focuses on the ongoing funding disparity in women’s health research and innovation and why greater investment is essential to improving care; the process and challenges of bring clinically validated therapies to market for women; how can women be more informed consumers and spot junk science, especially in the menopause space right now where marketing often outpaces the clinical evidence; and, more. In 2015, Sabrina Martucci Johnson founded Daré Bioscience, a purpose-driven health biotech company built on a single, uncompromising premise: women deserve better. Not incrementally better. Categorically better. From contraception and menopause to vaginal health, sexual health, fertility, and infectious disease. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare. Key topics covered What "clinically validated" actually means and why extensive testing is required before therapies reach patients How existing FDA-approved medicines can be thoughtfully adapted to address unmet needs in women's health The differences between FDA-approved medications, compounded prescriptions, and products manufactured under pharmaceutical quality standards Why women should ask more questions about the medications they're prescribed, including whether a treatment has been clinically studied and published in peer-reviewed research How telehealth and social media have expanded access to information while also making it more important than ever to evaluate healthcare claims carefully The importance of helping women become informed healthcare consumers who can confidently advocate for themselves Why raising expectations for women's healthcare is one of the most important steps toward lasting change This episode delivers an informative conversation about the science, investment, and persistence required to bring innovative women's health therapies to market. Claire and Sabrina encourage women to ask thoughtful questions, seek evidence-based information, and expect the same level of scientific rigor and innovation that has long been standard in other areas of medicine. The discussion offers both practical guidance and optimism for the future of women's healthcare. Connect with Sabrina: Websites: https://www.darebioscience.com https://www.daretoplaybio.com Instagram: https://www.instagram.com/darebioscience LinkedIn: https://www.linkedin.com/in/sabrina-johnson-27799829/ https://www.linkedin.com/company/dare-bioscience/
